Shover, Chelsea L. PhD; Falasinnu, Titilola O. PhD; Freedman, Rohan B.; Humphreys, Keith PhD
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA (CLS); Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (TOF); Brown University, Providence, RI (RBF); Veterans Affairs Palo Alto Health Care System, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA (KH).
Send correspondence to Chelsea L. Shover, PhD, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 1070 Arastradero Rd., Ste 200, Palo Alto, CA 94304. E-mail: [email protected].
Received 23 June, 2020
Accepted 14 October, 2020
CLS and TOF were supported by National Institute on Drug Abuse T32 DA035165. KH was supported by grants from the U.S. Veterans Health Administration. CLS and KH were supported by the Wu Tsai Neurosciences Institute. RBF has nothing to declare.
The authors report no conflicts of interest.
